Johnson & Johnson Stock-Based Compensation 2010-2025 | JNJ
Johnson & Johnson annual/quarterly stock-based compensation history and growth rate from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
- Johnson & Johnson stock-based compensation for the quarter ending March 31, 2025 was $288M, a 4.64% decline year-over-year.
- Johnson & Johnson stock-based compensation for the twelve months ending March 31, 2025 was $3.045B, a 2.9% decline year-over-year.
- Johnson & Johnson annual stock-based compensation for 2024 was $1.176B, a 1.2% increase from 2023.
- Johnson & Johnson annual stock-based compensation for 2023 was $1.162B, a 2.11% increase from 2022.
- Johnson & Johnson annual stock-based compensation for 2022 was $1.138B, a 0.26% increase from 2021.
Johnson & Johnson Annual Stock-Based Compensation
(Millions of US $) |
| 2024 |
$1,176 |
| 2023 |
$1,162 |
| 2022 |
$1,138 |
| 2021 |
$1,135 |
| 2020 |
$1,005 |
| 2019 |
$977 |
| 2018 |
$978 |
| 2017 |
$962 |
| 2016 |
$878 |
| 2015 |
$874 |
| 2014 |
$792 |
| 2013 |
$728 |
| 2012 |
$662 |
| 2011 |
$621 |
| 2010 |
$614 |
| 2009 |
$628 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$365.747B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
